Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Shareholders??? Equity (Tables)

v3.25.1
Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2024
Shareholders’ Equity [Abstract]  
Schedule of Stock Option Activity

A summary of the stock option activity under the Company’s equity plans during the years ended December 31, 2024, 2023 and 2022 is as follows:

 

    Outstanding
share
options
   

Weighted-

average
exercise
price ($)

    Weighted
average
remaining
contractual
life (years)
    Aggregate
intrinsic
value ($ in
thousands)
 
Options:                        
                         
Outstanding as of December 31, 2021     5,461,337       3.102       5.363       16,713,971  
                                 
Granted     1,630,142       6.833                  
Forfeited     (468,814 )     5.557                  
Exercised     (570,451 )     0.482                  
                                 
Outstanding as of December 31, 2022     6,052,214       4.166       5.570       7,761,705  
                                 
Granted     430,874       2.728                  
Forfeited     (351,671 )     7.767                  
Exercised     (1,074,162 )     0.654                  
                                 
Outstanding as of December 31, 2023     5,057,255       4.543       5.662       2,352,517  
                                 
Granted     80,000       1.91                  
Forfeited     (291,124 )     6.08                  
Exercised     (255,756 )     0.81                  
                                 
Outstanding as of December 31, 2024     4,590,375       4.62       5.87       1,364,975  
                                 
Exercisable as of December 31, 2024     3,716,507       4.43       5.42       1,364,975  
                                 
Options available for future grants     531,969                          
Schedule of RSUs Activity

A summary of the Company’s RSUs activity during the years ended December 31, 2024, 2023 and 2022 is as follows:

 

    Numbers of RSUs  
RSUs:      
       
Outstanding as of December 31, 2021   $ 1,968,794  
Granted     1,619,898  
Forfeited     (417,025 )
Vested     (573,583 )
         
Outstanding as of December 31, 2022     2,598,084  
Granted     2,908,983  
Forfeited     (370,067 )
Vested     (895,170 )
         
Outstanding as of December 31, 2023     4,241,830  
Granted     4,377,834  
Forfeited     (432,018 )
Vested     (3,274,523 )
         
Outstanding as of December 31, 2024     4,913,123  
Schedule of Compensation to Employees

The following table sets forth the parameters used in computation of the options compensation to employees and service providers:

 

   

Year ended December 31

 
    2024     2023     2022  
                   
Expected term, in years     6.11       5.82       4.41-6.11  
Expected volatility     51.75 %     47%-51.75 %     47%-48 %
Risk-free interest rate     4.23 %     4.15%-4.55 %     1.74%-3.96 %
Expected dividend yield     0 %     0 %     0 %
Schedule of Share Based Compensation Expense

The following table presents stock-based compensation expense to employees included in the Company’s consolidated statements of operations:

 

    Year ended December 31,  
    2024     2023     2022  
                   
Research and development   $ 9,684     $ 8,721     $ 5,726  
Sales and marketing     2,384       2,229       1,403  
General and administrative     2,187       1,786       1,537  
Cost of revenues     287       276       127  
                         
Total stock-based compensation expense   $ 14,542     $ 13,012     $ 8,793